PMCB News and Press, PharmaCyte Biotech Inc.

2024-05-21 09:16:11 ET More on MyMD Pharmaceuticals, PharmaCyte Biotech, Inc., etc. Financial information for MyMD Pharmaceuticals Financial information for PharmaCyte Biotech, Inc. Read the full article on Seeking Alpha For further details see: PharmaCyt...

Second external investment in life sciences solidifies previously announced strategy to utilize significant cash position to create additional stockholder value PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”), today announced a $7 mi...

2024-03-19 06:53:28 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips PharmaCyte Biotech (NASDAQ: PMCB ) just reported results for the third quarter of 2024. PharmaCyte Biotech reported earnings per share of -65 cents. The company did no...

2023-12-18 11:51:33 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips PharmaCyte Biotech (NASDAQ: PMCB ) just reported results for the second quarter of 2024. PharmaCyte Biotech reported earnings per share of -26 cents. The company did n...

Epiroc AB ADR (EPOKY) is expected to report for Q3 2023 Sysmex Corporation ADR (SSMXY) is expected to report for Q2 2024 Streamline Health Solutions Inc. (STRM) is expected to report for Q1 2024 Helix Biopharma Corp. (HBPCF) is expected to report for Q2 2024 Standard Chartered plc...

New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder value PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”) announces it has made a $5 million investment in Femasys...

- $6.85 million upfront investment provides $23 million total cash runway into second half 2025 - - Financing allows for focused commercial team to bring Femasys’ infertility-related products to women in the U.S. - - Additional financing supports the advancement of Femasy...

Company prepares for comprehensive discussion with FDA to determine appropriate next steps for technology while evaluating additional opportunities PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”) provides an update on its investigati...

Software AG ADR (STWRY) is expected to report for Q2 2023 Dai Nippon Printing Co Ltd ADR (DNPLY) is expected to report for quarter end 2023-06-30 Coffee Holding Co. Inc. (JVA) is expected to report for Q1 2024 Calloway`s Nursery, Inc. (CLWY) is expected to report for Q2 2023 Home ...

PharmaCyte Biotech Inc. (PMCB) is expected to report for quarter end 2023-07-31